Journal:
:acta medica iranica
0
parisa goodarzi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.
babak arjmand clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran. and endocrinology and metabolism research center, endocrinology and metabolism research institute, tehran university of medical sciences. tehran, iran.
seyed hassan emami-razavi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.
masoud soleimani department of hematology, tarbiat modares university, tehran, iran.
abbas khodadadi iranian tissue bank, research and preparation center, tehran university of medical sciences, tehran, iran.
fereshteh mohamadi-jahani clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.
nowadays, cell -based and tissue engineered products have opened new horizons in treatment of incurable nervous system disorders. the number of studies on the role of schwann cells (sc) in treating nervous disorders is higher than other cell types. different protocols have been suggested for isolation and expansion of sc which most of them have used multiple growth factors, mitogens and fetal b...